TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·E. COLI SEPTICEMIA·+44
APP/PREMIERPRO
Drugs that treat it
Common E. coli osteomyelitis therapies.
CEFTRIAXONE (ceftriaxone sodium)
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+80
FRESENIUS KABI
TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·E. COLI SEPTICEMIA·+44
FRESENIUS KABI
TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·E. COLI SEPTICEMIA·+44
CLARIS/BAXTER
CEFTRIAXONE (ceftriaxone sodium)
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+80
REMEDYREPACK, I
Filter & compare in the drug finder →Opens the drug finder with E. coli osteomyelitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonE.
coli osteomyelitis is an inflammatory bone and bone marrow infection caused by the Gram-negative bacillus *Escherichia coli*.
It predominantly affects the musculoskeletal system, most commonly involving the vertebral column, long bones, or pelvic bones.
While relatively uncommon compared to Gram-positive bone infections, it frequently arises in elderly individuals, patients with diabetes mellitus, or immunocompromised hosts.
Pathophysiologically, it typically develops via hematogenous dissemination—often secondary to antecedent bacteremia originating from a urinary tract or intra-abdominal focus—or through contiguous spread from adjacent soft-tissue infections or surgical inoculation.
Hallmark clinical features include localized bone pain, tenderness, erythema, fever, progressive osseous destruction, and potentially systemic signs of infection or abscess formation.
- nih.gov
E. coli osteomyelitis is an inflammatory bone and bone marrow infection caused by the Gram-negative bacillus *Escherichia coli* While relatively uncommon compared to Gram-positive bone infections, it frequently arises in elderly individuals, patients with diabetes mellitus, or immunocompromised hosts Hallmark clinical features include localized bone pain, tenderness, erythema, fever, progressive osseous destruction, and potentially systemic signs of infection or abscess formation
- nih.gov
E. coli osteomyelitis is an inflammatory bone and bone marrow infection caused by the Gram-negative bacillus *Escherichia coli*
- nih.gov
It predominantly affects the musculoskeletal system, most commonly involving the vertebral column, long bones, or pelvic bones While relatively uncommon compared to Gram-positive bone infections, it frequently arises in elderly individuals, patients with diabetes mellitus, or immunocompromised hosts Pathophysiologically, it typically develops via hematogenous dissemination—often secondary to antecedent bacteremia originating from a urinary tract or intra-abdominal focus—or through contiguous spr...
- nih.gov
It predominantly affects the musculoskeletal system, most commonly involving the vertebral column, long bones, or pelvic bones
- nih.gov
While relatively uncommon compared to Gram-positive bone infections, it frequently arises in elderly individuals, patients with diabetes mellitus, or immunocompromised hosts Pathophysiologically, it typically develops via hematogenous dissemination—often secondary to antecedent bacteremia originating from a urinary tract or intra-abdominal focus—or through contiguous spread from adjacent soft-tissue infections or surgical inoculation
- nih.gov
Hallmark clinical features include localized bone pain, tenderness, erythema, fever, progressive osseous destruction, and potentially systemic signs of infection or abscess formation
- nih.gov
Hallmark clinical features include localized bone pain, tenderness, erythema, fever, progressive osseous destruction, and potentially systemic signs of infection or abscess formation
Personalize your experience
Follow E. coli osteomyelitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.